Wird geladen...
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence
Immune checkpoint inhibitors (ICPIs) are considered one of the most important breakthroughs in cancer treatment of the past decade; notably, different studies of programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors have reported impressive clinical activity and dur...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Respir Dis |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933587/ https://ncbi.nlm.nih.gov/pubmed/28818019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465817725486 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|